BIOMARIN PHARMACEUTICAL INC. (a Delaware corporation) 1,500,000 Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • March 6th, 2014 • Biomarin Pharmaceutical Inc • Pharmaceutical preparations • New York
BioMarin Pharmaceutical Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Merrill Lynch, Pierce, Fenner & Smith Incorporated (the “Underwriter”), with respect to the sale by the Company and the purchase by the Underwriter of 1,500,000 shares of Common Stock, par value $0.001 per share, of the Company (“Common Stock”). Such 1,500,000 shares of Common Stock to be sold by the Company are referred to herein as the “Securities.”
